Insmed Capital Expenditures from 2010 to 2024

INSM Stock  USD 75.16  0.72  0.95%   
Insmed Capital Expenditures yearly trend continues to be very stable with very little volatility. Capital Expenditures is likely to grow to about 14 M this year. During the period from 2010 to 2024, Insmed Capital Expenditures quarterly data regression pattern had sample variance of 112.6 T and median of  5,351,000. View All Fundamentals
 
Capital Expenditures  
First Reported
1999-03-31
Previous Quarter
6.8 M
Current Value
3.7 M
Quarterly Volatility
2.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Insmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insmed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.1 M, Interest Expense of 85.8 M or Total Revenue of 320.5 M, as well as many indicators such as Price To Sales Ratio of 13.55, Dividend Yield of 0.0 or Days Sales Outstanding of 47.02. Insmed financial statements analysis is a perfect complement when working with Insmed Valuation or Volatility modules.
  
Check out the analysis of Insmed Correlation against competitors.

Latest Insmed's Capital Expenditures Growth Pattern

Below is the plot of the Capital Expenditures of Insmed Inc over the last few years. Capital Expenditures are funds used by Insmed Inc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Insmed operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is Insmed's Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insmed's overall financial position and show how it may be relating to other accounts over time.
Capital Expenditures10 Years Trend
Slightly volatile
   Capital Expenditures   
       Timeline  

Insmed Capital Expenditures Regression Statistics

Arithmetic Mean8,434,785
Geometric Mean3,705,331
Coefficient Of Variation125.80
Mean Deviation6,936,863
Median5,351,000
Standard Deviation10,610,928
Sample Variance112.6T
Range42.2M
R-Value0.51
Mean Square Error90T
R-Squared0.26
Significance0.05
Slope1,204,293
Total Sum of Squares1576.3T

Insmed Capital Expenditures History

202414 M
202313.3 M
20229.9 M
20217.3 M
20206.8 M
201942.3 M
201814.8 M

About Insmed Financial Statements

Insmed investors utilize fundamental indicators, such as Capital Expenditures, to predict how Insmed Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Capital Expenditures13.3 M14 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out the analysis of Insmed Correlation against competitors.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.55)
Revenue Per Share
2.206
Quarterly Revenue Growth
0.182
Return On Assets
(0.26)
Return On Equity
(8.91)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.